‌

US Patent 10683308 Rapamycin analogs and uses thereof

Patent 10683308 was granted and assigned to Navitor Pharmaceuticals on June, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Navitor Pharmaceuticals

Current Assignee

Navitor Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10683308

Date of Patent

June 16, 2020

Patent Application Number

15758861

Date Filed

September 9, 2016

Patent Citations

‌

US Patent 10117945 mTORC1 inhibitors

Patent Citations Received

‌

US Patent 11819476 Rapamycin analogs and uses thereof

‌

US Patent 11603377 MTORC1 modulators and uses thereof

‌

US Patent 11634432 mTORC1 modulators and uses thereof

‌

US Patent 11702429 mTORC modulators and uses thereof

‌

US Patent 11021492 mTORC modulators and uses thereof

Patent Primary Examiner

‌

Po-Chih Chen

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10683308 Rapamycin analogs and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API